Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | IBI351 |
Trade Name | |
Synonyms | GFH925|GFH-925|GFH 925|IBI 351|IBI-351 |
Drug Descriptions |
IBI351 is a KRAS G12C inhibitor with potential anti-tumor activity (J Clin Oncol 40, no. 16_suppl (June 01, 2022) 3110). |
DrugClasses | KRAS G12C inhibitor 33 |
CAS Registry Number | NA |
NCIT ID | C182070 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + IBI351 | Cetuximab IBI351 | 0 | 1 |
IBI351 | IBI351 | 0 | 0 |